168 related articles for article (PubMed ID: 37993654)
21. An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinoma.
Liu Z; Sun L; Peng X; Liu S; Zhu Z; Huang C
Apoptosis; 2023 Dec; 28(11-12):1564-1583. PubMed ID: 37580435
[TBL] [Abstract][Full Text] [Related]
22. A prognostic signature of fatty acid metabolism-related genes for predicting survival of gastric cancer patients.
Zhao B; Jiang W; Wang J; Sheng G; Wang Y; Meng K; Yang T
J Biochem Mol Toxicol; 2024 Apr; 38(4):e23687. PubMed ID: 38515005
[TBL] [Abstract][Full Text] [Related]
23. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
[No Abstract] [Full Text] [Related]
24. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
Chen Y; He J; Jin T; Zhang Y; Ou Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
[TBL] [Abstract][Full Text] [Related]
25. Discovery of a novel lipid metabolism-related gene signature to predict outcomes and the tumor immune microenvironment in gastric cancer by integrated analysis of single-cell and bulk RNA sequencing.
Zhang J; Wang H; Tian Y; Li T; Zhang W; Ma L; Chen X; Wei Y
Lipids Health Dis; 2023 Dec; 22(1):212. PubMed ID: 38042786
[TBL] [Abstract][Full Text] [Related]
26. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
27. Metabolism reprogramming signature associated with stromal cells abundance in tumor microenvironment improve prognostic risk classification for gastric cancer.
Huo J; Guan J; Li Y
BMC Gastroenterol; 2022 Jul; 22(1):364. PubMed ID: 35907819
[TBL] [Abstract][Full Text] [Related]
28. COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing.
Chen M; Zhu X; Zhang L; Zhao D
BMC Med Genomics; 2023 Sep; 16(1):220. PubMed ID: 37723519
[TBL] [Abstract][Full Text] [Related]
29. The landscape of enhancer RNA identify prognosis-related molecular subtypes in gastric cancer.
Yan A; Chen Y; Bian R; Wang C; Que H; Shen Y; Lu X
Cancer Med; 2023 Jan; 12(2):2046-2057. PubMed ID: 35801342
[TBL] [Abstract][Full Text] [Related]
30. Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB.
Xiong S; Li S; Zeng J; Nie J; Liu T; Liu X; Chen L; Fu B; Deng J; Xu S
Front Immunol; 2023; 14():1253586. PubMed ID: 37790935
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
Front Immunol; 2022; 13():977338. PubMed ID: 36159818
[TBL] [Abstract][Full Text] [Related]
32. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
33. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
34. Five EMT-related genes signature predicts overall survival and immune environment in microsatellite instability-high gastric cancer.
Zhang M; Cao C; Li X; Gu Q; Xu Y; Zhu Z; Xu D; Wei S; Chen H; Yang Y; Gao H; Yu L; Li J
Cancer Med; 2023 Jan; 12(2):2075-2088. PubMed ID: 35789544
[TBL] [Abstract][Full Text] [Related]
35. TGFβ-Associated Signature Predicts Prognosis and Tumor Microenvironment Infiltration Characterization in Gastric Carcinoma.
Liu S; Li Z; Li H; Wen X; Wang Y; Chen Q; Xu X
Front Genet; 2022; 13():818378. PubMed ID: 35664335
[No Abstract] [Full Text] [Related]
36. Construction of a lipid metabolism-related and immune-associated prognostic score for gastric cancer.
Dai J; Li Q; Quan J; Webb G; Liu J; Gao K
BMC Med Genomics; 2023 May; 16(1):93. PubMed ID: 37138287
[TBL] [Abstract][Full Text] [Related]
37. Integrated analysis of 1804 samples of six centers to construct and validate a robust immune-related prognostic signature associated with stromal cell abundance in tumor microenvironment for gastric cancer.
Huo J; Guan G; Cai J; Wu L
World J Surg Oncol; 2022 Jan; 20(1):4. PubMed ID: 34983559
[TBL] [Abstract][Full Text] [Related]
38. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
Li T; Gao X; Han L; Yu J; Li H
World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
[TBL] [Abstract][Full Text] [Related]
39. NF-
Chen Q; Du X; Hu S; Huang Q
Biomed Res Int; 2022; 2022():5092505. PubMed ID: 35036435
[TBL] [Abstract][Full Text] [Related]
40. Identification of N7-methylguanosine related subtypes and construction of prognostic model in gastric cancer.
Li X; Dong H; Chen L; Wang Y; Hao Z; Zhang Y; Jiao Y; Zhao Z; Peng X; Zhan X
Front Immunol; 2022; 13():984149. PubMed ID: 36300121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]